Showing results (1-10 of 539) with videos related to
Sort By:
Pageof 54
Leukemia|January 30, 2019
Is lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma?Giovanni Barosi, Robert Peter GaleLeukemia Research|February 8, 2011
Bone marrow fibrosis in myeloproliferative neoplasms-associated myelofibrosis: deconstructing a myth?Giovanni Barosi, Robert Peter GaleLeukemia|March 4, 2023
Myelofibrosis-type megakaryocyte dysplasia (MTMD) as a distinct category of BCR::ABL-negative myeloproliferative neoplasms. Challenges and perspectivesGiovanni Barosi, Vittorio Rosti, Robert Peter GaleOncotargets and Therapy|June 10, 2015
Critical appraisal of the role of ruxolitinib in myeloproliferative neoplasm-associated myelofibrosisGiovanni Barosi, Vittorio Rosti, Robert Peter GaleMediterranean Journal of Hematology and Infectious Diseases|May 19, 2021
Cost-Effectiveness of Post-Autotransplant Lenalidomide in Persons with Multiple MyelomaMonia Marchetti, Robert Peter Gale, Giovanni BarosiHaematologica|May 21, 2026
Response to Comment on: "Clonal megakaryocyte dysplasia with normal blood values: a covert, thrombosis-prone, early myeloproliferative neoplasm."Giovanni Barosi, Vittorio Rosti, Luca Malcovati, et al.Blood Reviews|March 11, 2026
Ph-chromosome-negative myeloproliferative neoplasms: clonal dynamics are the name of the gameMohammadamin Noorafrooz, Ramin Noorafrooz, Giovanni Barosi, et al.Genes|August 27, 2021
Clinical Relevance of <i>VEGFA</i> (rs3025039) +936 C>T Polymorphism in Primary Myelofibrosis: Susceptibility, Clinical Co-Variates, and OutcomesLaura Villani, Adriana Carolei, Vittorio Rosti, et al.British Journal of Haematology|June 24, 2025
Primary myelofibrosis with increased haemoglobin concentration at presentationGiovanni Barosi, Rita Campanelli, Paolo Catarsi, et al.Expert Review of Hematology|July 12, 2012
Emerging targeted therapies in myelofibrosisGiovanni BarosiPageof 54